These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34746460)

  • 41. Determination of drug susceptibility and DNA fingerprint patterns of clinical isolates of Mycobacterium tuberculosis from Kampala, Uganda.
    Joloba ML; Whalen CC; Cave DM; Eisenach KD; Johnson JL; Okwera A; Morrissey A; Bajaksouzian S; Feagin J; Mugerwa R; Ellner J; Jacobs MR
    East Afr Med J; 2000 Feb; 77(2):111-5. PubMed ID: 10774085
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular epidemiology study of Mycobacterium tuberculosis and its susceptibility to anti-tuberculosis drugs in Indonesia.
    Lisdawati V; Puspandari N; Rif'ati L; Soekarno T; M M; K S; Ratnasari L; Izzatun N; Parwati I
    BMC Infect Dis; 2015 Aug; 15():366. PubMed ID: 26297576
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Using of the Sensititre MycoTB Plate Method for the Detection of Anti-tuberculous Drug Susceptibility of Rifampin Resistant Mycobacterium tuberculosis Complex Isolates].
    Ceyhan İ; Vezir S
    Mikrobiyol Bul; 2020 Apr; 54(2):211-222. PubMed ID: 32723277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Molecular Screening Versus Phenotypic Susceptibility Testing of Multidrug-Resistant Mycobacterium tuberculosis Isolates for Streptomycin and Ethambutol.
    Al-Mutairi NM; Ahmad S; Mokaddas E
    Microb Drug Resist; 2018 Sep; 24(7):923-931. PubMed ID: 29336677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distribution patterns of drug resistance Mycobacterium tuberculosis among HIV negative and positive tuberculosis patients in Western Kenya.
    Ogwang MO; Imbuga M; Ngugi C; Mutharia L; Magoma G; Diero L
    BMC Infect Dis; 2021 Nov; 21(1):1175. PubMed ID: 34809602
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mycobacterium tuberculosis Complex Drug Resistance in a High Tuberculosis Incidence Area from the WHO Eastern Mediterranean Region.
    Mansoori N; Douraghi M; Rajabloo AA; Taziki M; Yaseri M; Vaziri F
    J Pharm Pharm Sci; 2017; 20(1):428-434. PubMed ID: 29197427
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Epidemiology and Genetic Diversity of Multidrug-Resistant Mycobacterium tuberculosis Isolates in Bangladesh.
    Rahman SMM; Rahman A; Nasrin R; Ather MF; Ferdous SS; Ahmed S; Uddin MKM; Khatun R; Sarker MS; Mahmud AM; Rahman MM; Banu S
    Microbiol Spectr; 2022 Feb; 10(1):e0184821. PubMed ID: 35196788
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug resistance among Mycobacterium tuberculosis isolates in Lebanon.
    Hamze MM; Araj GF
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):314-8. PubMed ID: 9432386
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined Genotypic, Phylogenetic, and Epidemiologic Analyses of Mycobacterium tuberculosis Genetic Diversity in the Rhône Alpes Region, France.
    Pichat C; Couvin D; Carret G; Frédénucci I; Jacomo V; Carricajo A; Boisset S; Dumitrescu O; Flandrois JP; Lina G; Rastogi N
    PLoS One; 2016; 11(4):e0153580. PubMed ID: 27128522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Population structure of multidrug-resistant Mycobacterium tuberculosis clinical isolates in Colombia.
    Rodríguez-Castillo JG; Llerena C; Argoty-Chamorro L; Guerra J; Couvin D; Rastogi N; Murcia MI
    Tuberculosis (Edinb); 2020 Dec; 125():102011. PubMed ID: 33137696
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Underestimated pyrazinamide resistance may compromise outcomes of pyrazinamide containing regimens for treatment of drug susceptible and multi-drug-resistant tuberculosis in Tanzania.
    Juma SP; Maro A; Pholwat S; Mpagama SG; Gratz J; Liyoyo A; Houpt ER; Kibiki GS; Mmbaga BT; Heysell SK
    BMC Infect Dis; 2019 Feb; 19(1):129. PubMed ID: 30732572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relatively low primary drug resistant tuberculosis in southwestern Ethiopia.
    Abebe G; Abdissa K; Abdissa A; Apers L; Agonafir M; de-Jong BC; Colebunders R
    BMC Res Notes; 2012 May; 5():225. PubMed ID: 22574696
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 2008 and 2009. A report of the Australian Mycobacterium Reference Laboratory Network.
    Lumb R; Bastion I; Carter R; Jelfs P; Keehner T; Sievers A
    Commun Dis Intell Q Rep; 2011 Jun; 35(2):154-61. PubMed ID: 22010508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Multicenter evaluation of the indirect nitrate reductase assay for the rapid detection of multidrug-resistant tuberculosis].
    Çoban AY; Taştekin B; Uzun M; Kalaycı F; Ceyhan İ; Biçmen C; Albay A; Sığ AK; Özkütük N; Sürücüoğlu S; Özkütük A; Esen N; Albayrak N; Aslantürk A; Sarıbaş Z; Alp A
    Mikrobiyol Bul; 2016 Jan; 50(1):140-6. PubMed ID: 27058338
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia.
    Diriba G; Kebede A; Tola HH; Yenew B; Moga S; Addise D; Alemu A; Mohammed Z; Getahun M; Fantahun M; Tadesse M; Dagne B; Amare M; Assefa G; Abera D; Desta K
    PLoS One; 2020; 15(12):e0243493. PubMed ID: 33284842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extensive transmission of isoniazid resistant M. tuberculosis and its association with increased multidrug-resistant TB in two rural counties of eastern China: a molecular epidemiological study.
    Hu Y; Hoffner S; Jiang W; Wang W; Xu B
    BMC Infect Dis; 2010 Feb; 10():43. PubMed ID: 20187977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. First-line anti-tuberculosis drug resistance trends of Mycobacterium tuberculosis complex isolates. A tertiary hospital study in Turkey.
    Yazısız H; Hırçın Cenger D; Yazısız V; Kılıç L; Altın S
    Tuberk Toraks; 2019 Jun; 67(2):92-101. PubMed ID: 31414639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South Africa.
    Said HM; Kock MM; Ismail NA; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
    BMC Infect Dis; 2012 Dec; 12():369. PubMed ID: 23259765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.